Combination therapy with ribavirin and alpha interferon for the treatment of chronic hepatitis C refractory to interferon

Abstract

Combination of interferon-alpha and ribavirin is quite limited, both in scope and efficacy, in HCV patients who had a non-response to monotherapy with interferon. Better results may be expected in relapsers, but larger studies are necessary.